Arch Neurol. 1977 Jul;34(7):422-8.

Baclofen, a new antispastic drug. A controlled, multicenter trial in patients with multiple sclerosis.

Abstract

A double-blind, five-week, multicenter trial was conducted to compare the effect of baclofen, a unique amino acid derivative, with that of placebo in the treatment of 106 patients with spasticity secondary to multiple sclerosis. A spasticity assessment method that included a neurological examination, physicians' clinical impressions of changes during treatment, and a patient's self-evaluation was used to determine efficacy. This method showed baclofen (70 to 80 mg daily maximum, titrated) is effective relative to placebo in relieving symptoms of spasticity, such as flexor spasms, pain and stiffness, resistance to passive joint movements, and tendon stretch reflexes. Patient self-evaluation results also showed a significant reduction in clonus. Side effects were generally mild and transient.

PMID:: 327987; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

HighWire Press - PDF

Medical

Multiple Sclerosis - MedlinePlus Health Information

Supplemental Content

Related citations

An evaluation of baclofen treatment for certain symptoms in patients with spinal cord lesions. A double-blind, cross-over study. [Neurology. 1976]
An evaluation of baclofen treatment for certain symptoms in patients with spinal cord lesions. A double-blind, cross-over study.
Duncan GW, Shahani BT, Young RR. Neurology. 1976 May; 26(5):441-6.
The use of baclofen in treatment of spasticity in multiple sclerosis. [Can J Neurol Sci. 1979]
The use of baclofen in treatment of spasticity in multiple sclerosis.
Sawa GM, Paty DW. Can J Neurol Sci. 1979 Aug; 6(3):351-4.
Baclofen for spasticity in multiple sclerosis. Double-blind crossover and three-year study. [Neurology. 1978]
Baclofen for spasticity in multiple sclerosis. Double-blind crossover and three-year study.
Feldman RG, Kelly-Hayes M, Conomy JP, Foley JM. Neurology. 1978 Nov; 28(11):1094-8.
Review [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis]. [Wien Klin Wochenschr. 2001]
Review [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J, Entner T. Wien Klin Wochenschr. 2001; 113 Suppl 4:20-4.
Review Mitoxantrone: a review of its use in multiple sclerosis. [CNS Drugs. 2004]
Review Mitoxantrone: a review of its use in multiple sclerosis.
Scott LJ, Figgitt DP. CNS Drugs. 2004; 18(6):379-96.

See reviews... See all...

Cited by 1 PubMed Central article

Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice. [Ther Adv Neurol Disord. 2011]
Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice.
de Sa JC, Airas L, Bartholome E, Grigoriadis N, Mattle H, Oreja-Guevara C, O'Riordan J, Sellebjerg F, Stankoff B, Vass K, et al. Ther Adv Neurol Disord. 2011 May; 4(3):139-68.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Baclofen, a new antispastic drug. A controlled, multicenter trial in patients wi...
Baclofen, a new antispastic drug. A controlled, multicenter trial in patients with multiple sclerosis.
Arch Neurol. 1977 Jul ;34(7):422-8.

PubMed
Early rheumatoid arthritis: strategies for prevention and management.
Early rheumatoid arthritis: strategies for prevention and management.
Best Pract Res Clin Rheumatol. 2007 Feb ;21(1):27-42.

PubMed
State sales tax rates for soft drinks and snacks sold through grocery stores and...
State sales tax rates for soft drinks and snacks sold through grocery stores and vending machines, 2007.
J Public Health Policy. 2008 Jul ;29(2):226-49.

PubMed
Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-depend...
Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6.
Mol Cell Biol. 1995 May ;15(5):2672-81.

PubMed
Convergence of mitogenic signalling cascades from diverse classes of receptors a...
Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint.
Mol Cell Biol. 1996 Dec ;16(12):6917-25.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Baclofen, a new antispastic drug. A controlled, multicenter trial in patients with multiple sclerosis.

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Related citations

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information